Wissenschaft, Prostatakrebs, Statistik, Datenvisualisierung, R Project, News Politik & Staat Digitale Themen & Netzpolitik

Hamburg, Deutschland
Joined September 2016
Pierre Tennstedt retweeted
📣Calling for Papers📣 📚Advanced Molecular Research on #Diabetes #Pharmacology 👨‍🔬Guest Editor: Dr. Ioanna A. Anastasiou 🔗 Find Out More: mdpi.com/journal/ijms/specia… ⏰Submission Deadline: 20 Sep 2026 #CallforPapers #OpenAccess #MDPIIJMS #antidiabetic #drugs #insulin
3
2
138
Pierre Tennstedt retweeted
⭐Calling for Papers⭐ 📚Research into #Biomarkers for #Psychiatric Disorders 👨‍🔬Guest Editor: Dr. João Victor Silva Nani 🔗 Find Out More: mdpi.com/journal/ijms/specia… ⏰Submission Deadline: 31 Dec 2026 #CallforPapers #OpenAccess #MDPIIJMS #neuroimmune #neurogenomics
2
1
105
Compared to Goteborg 2 screening (PSA then MRI; NEJM) and PROSCREEN (PSA then marker then MRI; JAMA), BARCODE PRS based screening found fewer significant cancers (grade group 2+), more insignificant cancer and biopsied more men (the trifecta!). nejm.org/doi/full/10.1056/NE…
1
18
1
53
6,857
Pierre Tennstedt retweeted
Motor augmentation, involving motorized wearable devices like exoskeletons and robotic body parts, may enhance human capabilities beyond biological limits xitter.cf/visualfeastwang/status…
30
61
12
351
171,124
Pierre Tennstedt retweeted
Some myths about PSA screening mskcc.org/news/myths-about-p…
2
9
2
33
7,677
Pierre Tennstedt retweeted
(1/5) Unfassbar: @vonderleyen kassiert weiter den Umweltschutz in der #Landwirtschaft! Trotz fehlender Mehrheit bei den Mitgliedstaaten beschließt die @EU_commission heute ökologische Anforderungen auszusetzen, die in der #GAP geregelt sind. #GLÖZ8
8
43
3
106
4,629
Pierre Tennstedt retweeted
Want to learn more about prostate cancer ? And how we can use PSMA RLT ? Come to todays symposium with the outstanding clinicians @Tilki_De @ProfJOSullivan and Prof Maria de Santis @EANM_NucMed #eanm2023
5
16
1,842
Cloud-Anwendungen - Hacker-Angriff auf Microsoft war gravierend | tagesschau.de tagesschau.de/investigativ/s…
1
25
I'm happy to share my editorial in the special issue Immunotherapies for Cancer. mdpi.com/journal/ijms/specia… Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors mdpi.com/2295542 #mdpiijms via @IJMS_MDPI
2
116